RYCARMA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jan 2025 filing date already counts against anyone who files later.

Record

Serial number

99006283

Mark type

Stylized text

Filed

17 Jan 2025

Published for opposition

14 Oct 2025

Attorney of record

Matthew D. Asbell

Goods and services

• Class 005 — Pharmaceuticals: pharmaceutical preparations for that restoring normal intracellular calcium regulation; Chemical preparations for pharmaceutical or medical purposes, namely, for restoring normal intracellular calcium regulation; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders; chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders
• Class 042 — Scientific and technological services: Pharmaceutical research and development

Owner

• RyCarma Therapeutics, Inc., Boston, MA, US
• RyCarma Therapeutics, Inc., Boston, MA, US

Prosecution history

• 09 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 14 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 14 Oct 2025 — PUBLISHED FOR OPPOSITION
• 08 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 17 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 17 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 16 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 16 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 30 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 30 Jun 2025 — NON-FINAL ACTION E-MAILED
• 30 Jun 2025 — NON-FINAL ACTION WRITTEN
• 26 Jun 2025 — ASSIGNED TO EXAMINER
• 20 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 17 Jan 2025 — APPLICATION FILING RECEIPT MAILED
• 17 Jan 2025 — NEW APPLICATION ENTERED